Page last updated: 2024-10-28

hexylresorcinol and Carcinoma, Anaplastic

hexylresorcinol has been researched along with Carcinoma, Anaplastic in 3 studies

Research Excerpts

ExcerptRelevanceReference
"4‑Hexylresorcinol (4HR) is a pharmacologic chaperone."1.72Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation. ( Chae, WS; Kang, YJ; Kim, DW; Kim, SG; Rotaru, H; Yang, WG, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kang, YJ1
Yang, WG1
Chae, WS1
Kim, DW1
Kim, SG1
Rotaru, H1
KOSHIMURA, S1
MURASAWA, K1
NAKAGAWA, E1
UEDA, M1
BANDO, Y1
HIRATA, R1
KOSHIURA, RH1
KAGOTANI, Y1
UJIIE, T1

Other Studies

3 other studies available for hexylresorcinol and Carcinoma, Anaplastic

ArticleYear
Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation.
    Oncology reports, 2022, Volume: 48, Issue:3

    Topics: Apoptosis; Carcinoma; Cell Line, Tumor; DNA; Hexylresorcinol; Humans; Mouth Neoplasms; Mutation; Pro

2022
[Experimental anticancer studies. II. On the anti-tumor effect of 6-(2'-hydroxy-3', 5'-dihalophenylazo)-4-hexylresorcinol and related compounds on Yoshida sarcoma and Ehrlich ascites carcinoma in vivo].
    Gan, 1956, Volume: 47, Issue:3-4

    Topics: Animals; Antineoplastic Agents; Ascites; Carcinoma; Hexylresorcinol; Neoplasms; Sarcoma, Yoshida

1956
Experimental anticancer studies. XVI. Preparation and anticancer activity of 4-amino-6-hexylresorcinol on Ehrlich carcinoma in mice.
    Chemical & pharmaceutical bulletin, 1962, Volume: 10

    Topics: Animals; Antineoplastic Agents; Carcinoma; Hexylresorcinol; Mice

1962